These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36568581)

  • 1. Targeting resources efficiently and justifiably by combining causal machine learning and theory.
    Gur Ali O
    Front Artif Intell; 2022; 5():1015604. PubMed ID: 36568581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizability of heterogeneous treatment effects based on causal forests applied to two randomized clinical trials of intensive glycemic control.
    Raghavan S; Josey K; Bahn G; Reda D; Basu S; Berkowitz SA; Emanuele N; Reaven P; Ghosh D
    Ann Epidemiol; 2022 Jan; 65():101-108. PubMed ID: 34280545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous treatment effect analysis based on machine-learning methodology.
    Gong X; Hu M; Basu M; Zhao L
    CPT Pharmacometrics Syst Pharmacol; 2021 Nov; 10(11):1433-1443. PubMed ID: 34716669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rule ensemble method with adaptive group lasso for heterogeneous treatment effect estimation.
    Wan K; Tanioka K; Shimokawa T
    Stat Med; 2023 Aug; 42(19):3413-3442. PubMed ID: 37282988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical data.
    Lipkovich I; Svensson D; Ratitch B; Dmitrienko A
    Clin Trials; 2023 Aug; 20(4):380-393. PubMed ID: 37203150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth Bayesian network model for the prediction of future high-cost patients with COPD.
    Lin S; Zhang Q; Chen F; Luo L; Chen L; Zhang W
    Int J Med Inform; 2019 Jun; 126():147-155. PubMed ID: 31029256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
    Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
    Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests.
    Meiseles A; Paley D; Ziv M; Hadid Y; Rokach L; Tadmor T
    Comput Biol Med; 2022 Jun; 145():105490. PubMed ID: 35405402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine-guided discovery of a real-world rogue wave model.
    Häfner D; Gemmrich J; Jochum M
    Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2306275120. PubMed ID: 37983488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emulate randomized clinical trials using heterogeneous treatment effect estimation for personalized treatments: Methodology review and benchmark.
    Ling Y; Upadhyaya P; Chen L; Jiang X; Kim Y
    J Biomed Inform; 2023 Jan; 137():104256. PubMed ID: 36455806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explainable AI: A Review of Machine Learning Interpretability Methods.
    Linardatos P; Papastefanopoulos V; Kotsiantis S
    Entropy (Basel); 2020 Dec; 23(1):. PubMed ID: 33375658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials.
    Sinha P; Spicer A; Delucchi KL; McAuley DF; Calfee CS; Churpek MM
    EBioMedicine; 2021 Dec; 74():103697. PubMed ID: 34861492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis.
    Edward JA; Josey K; Bahn G; Caplan L; Reusch JEB; Reaven P; Ghosh D; Raghavan S
    Cardiovasc Diabetol; 2022 Apr; 21(1):58. PubMed ID: 35477454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Machine Learning in Resource Allocation Strategy over Vehicular Networks: A Survey.
    Nurcahyani I; Lee JW
    Sensors (Basel); 2021 Sep; 21(19):. PubMed ID: 34640858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explainable machine learning models based on multimodal time-series data for the early detection of Parkinson's disease.
    Junaid M; Ali S; Eid F; El-Sappagh S; Abuhmed T
    Comput Methods Programs Biomed; 2023 Jun; 234():107495. PubMed ID: 37003039
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.